论文信息 - Impact of prior vaccination with CovishieldTM and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study - 字舞流文

Impact of prior vaccination with CovishieldTM and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study

L. Jayaseelan | Karthik Gunasekaran | M. Moorthy | M. Joy | T. George | J. Peter | G. Varghese | P. Rupali | S. Jasmine | P. Mathews | D. Hazra | K. Abhilash | K. Pichamuthu | Richa Gupta | Ponnivalavan Mathiyalagan | Vivek Raja K. Krishnaraj | S. Selvan | R. Kanagarajan | Narmadha P. Reddy | N. Rajendiran | John Prasad Davis | Krupa George | T. J. Barney Isaac

[1] C. Midgley,et al. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021 , 2022, MMWR. Morbidity and mortality weekly report.

[2] S. Sinha,et al. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India , 2022, JAMA network open.

[3] William F. Fadel,et al. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings , 2021, The New England journal of medicine.

[4] I. Diamond,et al. Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK , 2021, medRxiv.

[5] V. Jha,et al. The High Mortality and Impact of Vaccination on COVID-19 in Hemodialysis Population in India During the Second Wave , 2021, Kidney International Reports.

[6] R. Myers,et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant , 2021, The New England journal of medicine.

[7] Aditi,et al. COVID-19 variants in India: Potential role in second wave and impact on vaccination , 2021, Heart & Lung.

[8] K. Abhilash. COVID-19 vaccines: Hope on the horizon with doubts , 2021 .

[9] Manish M Patel,et al. Postlicensure Evaluation of COVID-19 Vaccines. , 2020, JAMA.

[10] A. Farcomeni,et al. Features of severe COVID‐19: A systematic review and meta‐analysis , 2020, European journal of clinical investigation.

[11] Xue He,et al. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia , 2020, American Journal of Infection Control.

[12] World Health Organization,et al. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance , 2020, Pediatria i Medycyna Rodzinna.

[13] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[14] A. Costello,et al. Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings , 2015, Vaccine.

[15] F. Giostra,et al. [Non-invasive ventilation in acute respiratory failure]. , 2002, Revue des maladies respiratoires.

[16] Joseph M. Hilbe,et al. Modeling Count Data , 2014, International Encyclopedia of Statistical Science.

[17] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.